To help address the growing need for well-trained production personnel in the Life Sciences industry, Talentmark and Biotech Training Facility (BTF) are joining forces to accelerate the supply of GMP-qualified Operators.
Without proper GMP (Good Manufacturing Practice) knowledge, production processes can slow down, quality may be compromised, and safety risks increase. Well-trained operators are essential, and in short supply. This new collaboration aims to change that.
“No single organization can solve the Operator shortage alone,” says Robin van Woerden, Managing Director at Talentmark. “That’s why we are expanding our training partnership with Biotech Training Facility.”
By combining Talentmark’s expertise in talent acquisition with BTF’s practical training in GMP and cleanroom environments, the partnership ensures a greater influx of job-ready Operators. For companies, this translates to:
– A larger pool of qualified GMP Operator candidates
– Faster onboarding and quicker productivity
– Enhanced quality and consistency in production processes
“This collaboration enables us to structurally support companies facing production staff shortages by delivering targeted, hands-on training,” adds Judith van der Zwan, Senior Director Business Development at Biotech Training Facility.
As of June, the Leiden Bio Science Park team has been joined by Gerwin Zomer, who steps into the role of Account Manager Physical Living Environment. To get to know him a bit...
Researchers at the Leiden University Medical Center (LUMC) have announced promising early results from a clinical trial using lab-grown insulin-producing islet cells derived from...
VarmX has received IND approval for its Phase 3 trial of VMX‑C001, a recombinant factor X variant designed to neutralize FXa‑inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a €15 million EIC investment, this step positions VMX‑C001 to meet a gap in urgent haemostasis care.